Register entry
- Registered sites
- 1
- Active NDC listings
- 12
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Active ingredient (API) manufacture1Finished drug manufacture1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Altaire Pharmaceuticals Inc. | 311 West Lane, Aquebogue, New York (NY) 11931, United States (USA) | Active ingredient (API) manufacture, Finished drug manufacture | 1000119582786790378 |
Catalogue
Drug listings by form and route
1212 active NDC listings: 7 human prescription drug, 5 human otc drug. By marketing category: ANDA 4, OTC MONOGRAPH DRUG 4, UNAPPROVED DRUG OTHER 3, NDA 1.
| Dosage form | NDCs |
|---|---|
| solution | 5 |
| solution/ drops | 5 |
| ointment | 2 |
| Route | NDCs |
|---|---|
| ophthalmic | 12 |
| Labeller name on the listing | NDCs |
|---|---|
| altaire pharmaceuticals inc. | 12 |
Catalogue
Marketed products
12| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ALTAFLUOR | Fluorescein Sodium and Benoxinate Hydrochloride | solution, ophthalmic | 59390-218NDA |
| Altachlore Sodium Chloride Hypertonicity | Sodium Chloride | solution/ drops, ophthalmic | 59390-183OTC MONOGRAPH DRUG |
| Altachlore Sodium Chloride Hypertonicity Ophthalmic 5 Percent | Sodium Chloride | ointment, ophthalmic | 59390-184OTC MONOGRAPH DRUG |
| Altalube | Mineral oil and petrolatum | ointment, ophthalmic | 59390-198OTC MONOGRAPH DRUG |
| Ciprofloxacin HCl Ophthalmic | Ciprofloxacin Hydrochloride | solution, ophthalmic | 59390-217ANDA |
| Diclofenac | Diclofenac Sodium | solution/ drops, ophthalmic | 59390-149ANDA |
| Fluorescein Sodium and Proparacaine Hydrochloride | Fluorescein Sodium and Proparacaine Hydrochloride | solution/ drops, ophthalmic | 59390-205UNAPPROVED DRUG OTHER |
| Goniotaire | HYPROMELLOSE 2906 (4000 MPA.S) | solution, ophthalmic | 59390-182UNAPPROVED DRUG OTHER |
| HOMATROPINE HYDROBROMIDE OPHTHALMIC | Homatropine Hydrobromide | solution, ophthalmic | 59390-192UNAPPROVED DRUG OTHER |
| Multi-Action Relief | polyvinyl alcohol, povidone and tetrahydrozoline hydrochloride | solution/ drops, ophthalmic | 59390-156OTC MONOGRAPH DRUG |
| Naphazoline HCI And Pheniramine Maleate | NAPHAZOLINE HYDROCHLORIDE , PHENIRAMINE MALEATE | solution/ drops, ophthalmic | 59390-177ANDA |
| Ofloxacin ophthalmic | Ofloxacin | solution, ophthalmic | 59390-140ANDA |
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is Altaire Pharmaceuticals Inc. FDA approved?
- Altaire Pharmaceuticals Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Altaire Pharmaceuticals Inc.'s drugs manufactured?
- The FDA register lists Aquebogue, NY. Registered operations: active ingredient (API) manufacture, finished drug manufacture.
- What drugs does Altaire Pharmaceuticals Inc. make?
- 12 products are listed under Altaire Pharmaceuticals Inc. in the openFDA NDC Directory, most often as solution; solution/ drops; ointment. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.